Clinical trials
Completed trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19,267 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 141 |
| 2001 | 203 |
| 2002 | 295 |
| 2003 | 393 |
| 2004 | 485 |
| 2005 | 687 |
| 2006 | 735 |
| 2007 | 760 |
| 2008 | 873 |
| 2009 | 828 |
| 2010 | 893 |
| 2011 | 963 |
| 2012 | 1,020 |
| 2013 | 1,031 |
| 2014 | 1,040 |
| 2015 | 1,067 |
| 2016 | 1,022 |
| 2017 | 1,111 |
| 2018 | 1,065 |
| 2019 | 930 |
| 2020 | 697 |
| 2021 | 877 |
| 2022 | 691 |
| 2023 | 540 |
| 2024 | 328 |
| 2025 | 157 |
| 2026 | 33 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19,267 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 701 |
| University of British Columbia | 671 |
| University of Alberta | 478 |
| Novartis Pharmaceuticals | 384 |
| McMaster University | 383 |
| GlaxoSmithKline | 366 |
| The Hospital for Sick Children | 339 |
| Pfizer | 335 |
| Hoffmann-La Roche | 333 |
| AstraZeneca | 321 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 541 |
| Breast Neoplasms | 470 |
| Neoplasms | 439 |
| Prostatic Neoplasms | 338 |
| Obesity | 324 |
| Diabetes Mellitus | 317 |
| Asthma | 294 |
| Carcinoma, Non-Small-Cell Lung | 287 |
| Pulmonary Disease, Chronic Obstructive | 283 |
| Pain | 269 |
Trials
Showing 1 to 25 of 19,267. Each trial links to its page on Pharma Observatory.
19,167 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.